Credit: The Harvard Gazette, 2021

Dr. Micheal Mina joins us to share his research and work on a global immune observatory to prepare and test for the next pandemic. 

Dr. Michael Mina is the Chief Science Officer at eMed and was formerly Assistant Professor of Epidemiology at the Harvard T. H. Chan School of Public Health, a core member of the School’s Center for Communicable Disease Dynamics, and Associate Medical Director in Clinical Microbiology (molecular diagnostics) at Brigham and Women’s Hospital. You might recognize his name from Twitter where he shares relevant and important information on COVID, diagnostics testing and viral epidemiology with his 200,000 followers. 

Watch this 60-minute webinar to learn:

• What is a Global Immune Observatory and why do we need one 
• How Dr. Mina used OT-2s to automate his research 
• Advice for other labs looking to automate surveillance testing 
• Q and A with Dr. Mina

David Kim, Moderator

General Manager, Opentrons Robotics

Dr. Michael Mina, MD, PhD

Chief Medical Officer, eMED

Dr. Mina started his academic career as an Engineer at Dartmouth College. He earned his MD and PhD degrees from Emory University, with doctoral work in infectious disease Epidemiology & Immunology, split between CDC, St. Jude Children’s Research Hospital, the Respiratory and Meningeal Pathogens Research Unit in Johannesburg, South Africa and the Emory Vaccine Center. He completed his postdoctoral work at Princeton University in the Mathematics of Infectious Diseases with Prof. Bryan Grenfell and at Harvard Medical School in the Department of Genetics with Prof. Stephen Elledge. He completed his residency training in clinical pathology at Brigham and Women’s Hospital / Harvard Medical School.

Originally Aired 07/12/22